Blue Jet Healthcare Ltd (BLUEJET) is currently trading at 431.15 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Blue Jet Healthcare Limited is a science-driven pharmaceutical company specializing in the collaboration, development, and manufacturing of advanced pharmaceutical intermediates and APIs, including contrast media intermediates, high-intensity sweeteners, and pharma intermediates. Recent capacity expansions include acquiring a 103-acre site in Vizag aimed at enhancing their production capabilities, with strategic support from global customers, indicating a robust growth plan in line with future demand projections. The company's financial performance showcased significant growth, with a 40% increase in revenue in H1 FY26 compared to H1 FY25, reflective of effective portfolio diversification and strategic investments. Blue Jet Healthcare's strategic focus on backward integration and process optimization, notably in their contrast media intermediates, highlights their commitment to leveraging in-house R&D capabilities and technological advancements. Challenges such as transit delays have impacted quarterly financials, but the long-term outlook remains strong with substantial R&D investments and sustainability initiatives, such as energy from wind and solar contributing 70% of total energy consumption.

Over the past 52 weeks, Blue Jet Healthcare Ltd has traded between a low of ₹425.00 and a high of ₹1,028.20. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Blue Jet Healthcare Ltd has a market capitalization of approximately 7,863.19. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Blue Jet Healthcare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 22.32 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

You can buy shares of Blue Jet Healthcare Ltd (BLUEJET) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.

Based on its market capitalization of 7,863.19 Cr, Blue Jet Healthcare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Blue Jet Healthcare Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Blue Jet Healthcare Ltd is 22.32. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Blue Jet Healthcare Ltd pays dividends with a current dividend yield of 0.26%. Dividend-paying stocks may provide periodic income in addition to potential long-term capital appreciation.

Key risks associated with Blue Jet Healthcare Ltd include sector-specific challenges in the Pharmaceuticals industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.